This Page Intentionally Left Blank - Int Medical

Gastritis and peptic ulcer disease 223
32. Bodger K, Daly MJ, Heatley RV. Prescribing patterns for dyspepsia in primary
care: a prospective study of selected general practitioners. Aliment Pharmacol
Ther. 1996;10(6):889–895.
33. Quartero AO, Numans ME, de Melker RA, et al. Dyspepsia in primary care:
acid suppression as effective as prokinetic therapy. A randomized clinical
trial. Scand J Gastroenterol. 2001;36(9):942–947.
34. Pound SE, Heading RC. Diagnosis and treatment of dyspepsia in the elderly.
Drugs Aging. 1995;7(5):347–354.
35. Angelini G, Castagnini A, Rizzoli R, et al. Treatment of reflux gastritis: double
blind comparison between clebopride and domperidone. A preliminary
report. Ital J Gastroenterol. 1990;22(1):24–27.
36. Dallera F, Scanzi G, Gendarini A. [Prokinetic activity and antral inflammation.
Usefulness of cisapride combined with H2 antagonists in gastritis.] Clin Ter.
1994;144(1):23–26.
37. Koskenpato J, Punkkinen JM, Kairemo K, et al. Nizatidine and gastric emptying
in functional dyspepsia. Dig Dis Sci. 2008;53(2):352–357.
38. Wang WH, Huang JQ, Zheng GF, et al. Effects of proton-pump inhibitors on
functional dyspepsia: a meta-analysis of randomized placebo-controlled trials.
Clin Gastroenterol Hepatol. 2007;5(2):178–185; quiz 140.
39. Moayyedi P, Soo S, Deeks J, et al. Pharmacological interventions for non-ulcer
dyspepsia. Cochrane Database Syst Rev. 2006(4):CD001960.
40. Bytzer P, Talley NJ. Current indications for acid suppressants in dyspepsia.
Best Pract Res Clin Gastroenterol. 2001;15(3):385–400.
41. Dhali GK, Garg PK, Sharma MP. Role of anti-Helicobacter pylori treatment in
H. pylori-positive and cytoprotective drugs in H. pylori-negative, non-ulcer
dyspepsia: results of a randomized, double-blind, controlled trial in Asian
Indians. J Gastroenterol Hepatol. 1999;14(6):523–528.
42. Misra SP, Dwivedi M, Misra V, et al. Sucralfate versus ranitidine in non-ulcer
dyspepsia: results of a prospective, randomized, open, controlled trial. Indian
J Gastroenterol. 1992;11(1):7–8.
43. Moayyedi P, Soo S, Deeks J, et al. Systematic review: Antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia.
Aliment Pharmacol Ther. 2003;17(10):1215–1227.
44. Miwa H, Osada T, Nagahara A, et al. Effect of a gastro-protective agent,
rebamipide, on symptom improvement in patients with functional dyspepsia:
a double-blind placebo-controlled study in Japan. J Gastroenterol Hepatol.
2006;21(12):1826–1831.